ATS 2018 International Conference - Mobile

Matthias Bollinger

-

Actelion Pharmaceuticals Ltd.

Session(s)

The Selective Prostacyclin Receptor Agonist ACT-333679 Attenuates and Reverses TGFb1-Induc...
Tuesday, May 22 11:15 AM - 1:00 PM